← All organizations
Highest phase reached
Phase 2
First clinical trial
May 13, 2020Last known activity
Apr 1, 2025
Timeline
2000s
- Jun 1, 2009
Adaptive Biotechnologies— Founded
2010s
- Jan 7, 2015
Sequenta— Acquired
Drugs by trial phase (8 distinct, 5 trials)
Phase 2 (7 own, 0 via acquisition)
Other trials (0 own, 1 via acquisition)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (4)
- NCT06828991CollaboratorPhase 2Apr 1, 2025
- NCT06557330CollaboratorPhase 2Dec 31, 2024
- NCT06252675CollaboratorPhase 2Jun 11, 2024
- NCT04419519CollaboratorPhase 2May 13, 2020
Details
- Founded
- Seattle, WA, US Jun 1, 2009
- Last known activity
- Apr 1, 2025